Chris Hamby Profile Banner
Chris Hamby Profile Image
Chris Hamby

@ChrisDHamby

Followers
6,398
Following
535
Media
131
Statuses
3,391

Investigative reporter @NYTimes. Author of Soul Full of Coal Dust, in stores and online now: https://t.co/BQffThH14M. D.C. resident. Nashville native.

Joined September 2010
Don't wanna be here? Send us removal request.
Chris Hamby Retweeted
@SherylNYT
Sheryl Gay Stolberg
9 days ago
SCOOP: Top Operation Warp Speed official warned last June that Emergent BioSolutions, whose plant ruined 15 million Covid vaccine doses, posed "key risks" & would have to be "monitored closely," says report obtained by @nytimes w/@sharonlnyt @chrisdhamby https://t.co/xZ0dPJHQNl
22
160
312
@ChrisDHamby
Chris Hamby
9 days ago
Last June, a top Operation Warp Speed official warned about inadequate staffing and quality control problems at the facility that recently had to toss up to 15M doses of Covid-19 vaccine because of contamination, a report obtained by @nytimes shows: https://t.co/RWXQbDs7sC
7
45
116
Chris Hamby Retweeted
@nytimes
The New York Times
10 days ago
Officials with the firm, Emergent BioSolutions, claimed the mistake was an isolated incident, but our investigation found a pattern of lapses at the factory that suggests that the vaccine mix-up reflects deeper quality concerns. https://t.co/LCoFn2veCx https://t.co/hW5NslcpIz
Tweet media one
33
441
1K
@ChrisDHamby
Chris Hamby
10 days ago
The company that had to scrap up to 15 million doses of Covid-19 vaccine last week, Emergent BioSolutions, was also the subject of our recent investigation into why the nation's emergency medical stockpile was ill-prepared for the pandemic. https://t.co/rEo8UpBL87
0
1
4
@ChrisDHamby
Chris Hamby
10 days ago
The U.S. bet big on Emergent BioSolutions to manufacture Covid-19 vaccines, but our examination found the company has flouted rules and downplayed errors at its Baltimore plant. So far, not a single dose has been deemed usable. w/@SherylNYT & @SharonLNYT https://t.co/rOqeeWcOVf
1
5
4
Chris Hamby Retweeted
@SherylNYT
Sheryl Gay Stolberg
10 days ago
INVESTIGATION: The U.S. bet big on Emergent BioSolutions, the Maryland biotech whose Baltimore plant mixed up vaccine doses. Documents and internal audits obtained by @nytimes reveal a pattern of serious quality lapses. @ChrisDHamby @SharonLNYT & me. https://t.co/DTpHPQrLH3
134
716
1K
@ChrisDHamby
Chris Hamby
a month ago
White House press secretary Jen Psaki at today's briefing, when asked about our investigation of the nation's emergency medical reserve: "The administration is going to undertake a comprehensive review and audit of the national stockpile.” https://t.co/uQ5wGeMMoP
1
0
2
Chris Hamby Retweeted
@nytimes
The New York Times
a month ago
President Biden on Monday canceled a visit to a coronavirus vaccine plant run by Emergent BioSolutions after The New York Times published an investigation into how the company gained outsize influence over the nation’s emergency medical reserve. https://t.co/FYkpjhRkRT
22
88
291
@ChrisDHamby
Chris Hamby
a month ago
President Biden canceled his planned visit to the Emergent BioSolutions facility making coronavirus vaccines a day after our investigation into the company's tactics: https://t.co/uQ5wGeMMoP @SherylNYT @nytimes
0
2
9
Chris Hamby Retweeted
@SherylNYT
Sheryl Gay Stolberg
a month ago
A Maryland firm, Emergent BioSolutions, has used deep connections in DC to gain unrivaled dominance over the Strategic National Stockpile, which was woefully ill-prepared for the pandemic. @ChrisDHamby and I investigated. Here's a look at the key players: https://t.co/iq2IomISMt
3
12
21
Chris Hamby Retweeted
@nytimes
The New York Times
a month ago
The New York Times examined more than 40,000 pages of documents, some previously undisclosed, and interviewed more than 60 people with inside knowledge of the stockpile, revealing a deeply dysfunctional system that may have cost lives. Read more: https://t.co/ucECf6KNix
14
152
323
Chris Hamby Retweeted
@SherylNYT
Sheryl Gay Stolberg
a month ago
EXCLUSIVE: Why the Strategic National Stockpile was so ill-prepared for the pandemic. A well-connected biotech firm, Emergent BioSolutions, which now makes coronavirus vaccines, put an "extraordinary burden" on its budget. @ChrisDHamby & I investigated. https://t.co/kjLDzceBNy
54
385
588
Chris Hamby Retweeted
@nytimes
The New York Times
a month ago
Throughout most of the last decade, the government has spent nearly half of the stockpile’s half-billion-dollar annual budget on anthrax vaccines, The New York Times found, leaving the country woefully unprepared for pandemic response. https://t.co/ucECf6KNix https://t.co/alB6mlwjD0
Tweet media one
16
159
322
Chris Hamby Retweeted
@nytimes
The New York Times
a month ago
Last year, as the pandemic raced across the country, the U.S. government paid Emergent $626 million for products that included vaccines to fight an entirely different threat: a terrorist attack using anthrax. https://t.co/ucECf6KNix https://t.co/XT2EmwaIA6
Tweet media one
18
232
317
Chris Hamby Retweeted
@nytimes
The New York Times
a month ago
Government purchases for the Strategic National Stockpile, the emergency medical reserve, have been influenced by the demands of biotech firms. Chief among them is Emergent BioSolutions, a company now manufacturing coronavirus vaccines. https://t.co/ucECf6KNix https://t.co/vDuBna9Mmy
Tweet media one
12
136
234